de Carvalho RVH, Ersching J, Barbulescu A, Hobbs A, Castro TBR, Mesin L, Jacobsen JT, Phillips BK, Hoffmann H-H, Parsa R et al..  2023.  Clonal replacement sustains long-lived germinal centers primed by respiratory viruses.. Cell. 186(1):131-146.e13.

Yogev O, Weissbrod O, Battistoni G, Bressan D, Naamati A, Falciatori I, Berkyurek ACan, Rasnic R, Izuagbe R, Hosmillo M et al..  2023.  From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis.. Commun Biol. 6(1):277.

VarnBuhler BS, Moon J, Dey SKumar, Wu J, Jaffrey SR.  2022.  Detection of SARS-CoV-2 RNA Using a DNA Aptamer Mimic of Green Fluorescent Protein.. ACS Chem Biol. 17(4):840-853.

Bliss JW, Yau A, Beideck E, Novak JSS, d'Andrea FB, Blobel NJ, Batavia AS, Charney P.  2022.  A Medical Student-Run Telehealth Primary Care Clinic During the COVID-19 Pandemic: Maintaining Care for the Underserved.. J Prim Care Community Health. 13:21501319221114831.

Kao KS, Gupta A, Zong G, Li C, Kerschbaumer I, Borghi S, Achkar JM, Bournazos S, Wang L-X, Ravetch JV.  2022.  Synthetic nanobodies as tools to distinguish IgG Fc glycoforms.. Proc Natl Acad Sci U S A. 119(48):e2212658119.

McGary LHF, Vardhana SA.  2022.  Vive la Résistance: T-cell Immunity in the Protection against SARS-CoV-2 Infection.. Cancer Discov. 12(4):892-894.

Do MH, Stewart CR, Harp J.  2021.  Cutaneous Manifestations of COVID-19 in the Inpatient Setting.. Dermatol Clin. 39(4):521-532.

Duarte RRR, Copertino DC, Iñiguez LP, Marston JL, Bram Y, Han Y, Schwartz RE, Chen S, Nixon DF, Powell TR.  2021.  Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.. Mol Med. 27(1):105.

Greaney AJ, Starr TN, Barnes CO, Weisblum Y, Schmidt F, Caskey M, Gaebler C, Cho A, Agudelo M, Finkin S et al..  2021.  Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies.. Nat Commun. 12(1):4196.